US Stock MarketDetailed Quotes

Theravance Biopharma (TBPH)

Watchlist
  • 17.020
  • -0.020-0.12%
Close Sep 18 16:00 ET
  • 17.020
  • 0.0000.00%
Post 19:30 ET
883.66MMarket Cap16.37P/E (TTM)

Theravance Biopharma (TBPH) Cash Flow

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
Operating Cash Flow
-103.35%-6.97M
+70.26%73.28M
-572.28%-6.06M
-25.25%-6.51M
+4812.89%208.07M
+4311.25%43.04M
-5.62%-902.00K
-109.01%-5.20M
+64.50%-4.42M
+90.89%-1.02M
+99.31%-854.00K
+88.77%-2.49M
+15.57%-12.44M
+56.96%-11.22M
-192.35%-124.06M
+51.29%-22.14M
+70.61%-14.73M
+62.69%-26.07M
+34.64%-42.43M
+41.00%-45.45M
Net cash flow from continuing operations
-103.35%-6.97M
+70.26%73.28M
-572.28%-6.06M
-25.25%-6.51M
+4812.89%208.07M
+4311.25%43.04M
-5.62%-902.00K
-109.01%-5.20M
+64.50%-4.42M
+90.89%-1.02M
-101.56%-854.00K
+85.31%-2.49M
+9.40%-12.44M
+57.95%-11.22M
+221.35%54.91M
+76.00%-16.93M
+72.61%-13.73M
+61.81%-26.68M
+41.44%-45.25M
+8.42%-70.55M
Net Income from Continuing Operations
-110.76%-5.90M
+63.67%-4.93M
+493.02%61.02M
+128.47%3.62M
+431.75%54.84M
-16.42%-13.58M
-82.46%-15.53M
-41.88%-12.70M
-5.65%-16.53M
+47.19%-11.66M
+40.31%-8.51M
+42.32%-8.95M
+31.36%-15.65M
+45.14%-22.09M
+75.34%-14.26M
+79.36%-15.52M
+56.51%-22.79M
+49.47%-40.26M
+23.16%-57.82M
-2.08%-75.17M
Gain/Loss from Continuing Operations
----
----
-100.00%0.00
+100.00%0.00
----
----
+16400.00%163.00K
-16400.00%-163.00K
----
----
-101.14%-1.00K
-99.97%1.00K
+150.77%1.32M
+113.74%29.00K
--88.00K
--3.05M
-47.65%-2.61M
-104.44%-211.00K
----
----
Depreciation & Depletion & Amortization
-45.42%506.00K
-20.63%835.00K
-71.80%196.00K
-16.54%636.00K
-5.31%927.00K
-10.77%1.05M
-50.95%695.00K
-18.68%762.00K
+5.95%979.00K
+20.55%1.18M
-30.02%1.42M
-46.97%937.00K
-51.60%924.00K
-26.08%978.00K
+58.20%2.03M
-32.27%1.77M
-20.99%1.91M
-42.30%1.32M
+229.90%1.28M
+31.50%2.61M
Deferred Tax
+97.96%-218.00K
-61.93%-3.00M
+100.46%30.00K
+1004.44%994.00K
-1805.70%-10.69M
-261.01%-1.85M
-305.46%-6.59M
--90.00K
---561.00K
---513.00K
--3.21M
--0.00
--0.00
--0.00
----
----
----
----
----
----
Other Non-Cash Items
-95.87%26.00K
-93.05%42.00K
-8.55%588.00K
-12.54%551.00K
-2.33%629.00K
-3.97%604.00K
+3.21%643.00K
+3.45%630.00K
+13.38%644.00K
+14.36%629.00K
+13.27%623.00K
+29.30%609.00K
+129.65%568.00K
-70.57%550.00K
+2300.00%550.00K
+128.37%471.00K
-795.33%-1.92M
+3963.04%1.87M
+99.75%-25.00K
-118.42%-1.66M
Change in Working Capital
-104.67%-7.37M
+46.00%75.83M
-621.22%-72.38M
-4835.67%-16.88M
+5761.66%157.80M
+1161.22%51.94M
+506.77%13.89M
+74.57%-342.00K
+145.86%2.69M
+79.90%4.12M
-105.73%-3.41M
+91.17%-1.35M
-397.82%-5.87M
+157.93%2.29M
+1154.65%59.56M
-97.54%-15.23M
+115.06%1.97M
+69.86%-3.95M
+55.34%-5.65M
+53.41%-7.71M
-Change in Receivables
+26.96%-4.80M
+50.61%79.95M
-4744.64%-77.27M
+243.44%3.65M
-1898.90%-6.57M
+1789.22%53.09M
-282.49%-1.60M
-101.90%-2.55M
+110.35%365.00K
-37.76%2.81M
+84.39%-417.00K
+22.45%-1.26M
-1571.09%-3.53M
+152.52%4.52M
-4073.44%-2.67M
+8.70%-1.63M
+30.82%-211.00K
-54.77%1.79M
+98.16%-64.00K
-80.63%-1.78M
-Change in Prepaid Assets
+17.36%-1.25M
+653.85%1.67M
-120.37%-814.00K
-279.45%-1.18M
-309.25%-1.52M
-94.46%221.00K
+232.75%4.00M
+135.06%657.00K
+176.21%724.00K
+187.18%3.99M
-290.93%-3.01M
+54.30%-1.87M
-136.34%-950.00K
-82.52%1.39M
-73.55%1.58M
-189.84%-4.10M
+363.48%2.61M
+316.96%7.94M
+1685.33%5.96M
+132.01%4.57M
-Change in Payables and Accrued Expense
-104.51%-1.05M
-369.96%-6.34M
-24.78%-3.11M
-313.98%-14.51M
+1947.63%23.30M
+58.03%-1.35M
-216.79%-2.49M
+4482.43%6.78M
+136.52%1.14M
+3.69%-3.21M
-227.39%-786.00K
+102.31%148.00K
-488.53%-3.12M
+72.12%-3.34M
+109.65%617.00K
-23.22%-6.40M
+106.35%802.00K
+27.68%-11.96M
-184.62%-6.39M
-237.23%-5.19M
-Change in Other Current Assets
-99.77%330.00K
+364.93%1.34M
+214.36%223.00K
-340.00%-372.00K
+63353.10%142.95M
+1060.00%288.00K
+95.84%-195.00K
-89.86%155.00K
-150.67%-226.00K
-102.58%-30.00K
-20.20%-4.68M
+202.21%1.53M
+115.73%446.00K
+116000.00%1.16M
-11558.82%-3.90M
+25.31%-1.50M
-404.18%-2.84M
-98.46%1.00K
+102.01%34.00K
-310.62%-2.00M
-Change in Other Current Liabilities
-13.96%-1.94M
-42.11%-2.27M
-144.39%-1.89M
-11.16%-1.86M
-36.71%-1.70M
-31.14%-1.60M
-6.90%4.26M
-1508.40%-1.68M
-196.96%-1.24M
+15.13%-1.22M
+27041.18%4.58M
+107.45%119.00K
-27.71%1.28M
+15.99%-1.43M
+99.22%-17.00K
-220.04%-1.60M
+428.96%1.77M
-223.43%-1.71M
-973.60%-2.18M
-140.70%-499.00K
-Change In Other Working Capital
+0.91%1.33M
+14.71%1.47M
----
----
-31.66%1.32M
-27.85%1.29M
----
----
+38760.00%1.93M
+29783.33%1.78M
-98.59%903.00K
+0.00%-6.00K
+97.08%-5.00K
+33.33%-6.00K
+2228.70%63.95M
+99.79%-6.00K
+91.37%-171.00K
+99.77%-9.00K
+80.77%-3.00M
+61.50%-2.80M
Cash Flow from Discontinued Operating Activities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-6455.40%-178.97M
---5.21M
---1.00M
--615.00K
--2.82M
----
Net cash flow from investing
-66.59%-60.40M
+71.69%52.59M
-96.25%588.00K
-476.16%-100.25M
-1096.24%-36.26M
+79.89%30.63M
+2416.99%15.69M
-82752.38%-17.40M
-127.44%-3.03M
+139.56%17.03M
-101.73%-677.00K
-100.00%-21.00K
+47.00%11.05M
-234.84%-43.05M
+261.80%39.16M
+3104.52%1.08B
-78.99%7.52M
-71.92%31.92M
-79.33%10.82M
-153.79%-35.79M
Net Cash Flow from Continuing Investing Activities
-66.59%-60.40M
+71.69%52.59M
-96.25%588.00K
-476.16%-100.25M
-1096.24%-36.26M
+79.89%30.63M
+2416.99%15.69M
-82752.38%-17.40M
-127.44%-3.03M
+139.56%17.03M
-101.73%-677.00K
+99.89%-21.00K
+47.00%11.05M
-234.84%-43.05M
+261.80%39.16M
+44.89%-19.73M
-78.99%7.52M
-71.92%31.92M
-79.33%10.82M
-153.79%-35.79M
Net PPE Purchase and Sale
----
----
+95.79%-8.00K
+100.00%0.00
+5.56%-34.00K
+100.00%0.00
+71.94%-190.00K
+28.57%-15.00K
-107.98%-36.00K
+87.50%-91.00K
-154.51%-677.00K
-136.84%-21.00K
+569.79%451.00K
-145.53%-728.00K
+40.09%-266.00K
+105.52%57.00K
+38.46%-96.00K
+190.49%1.60M
+63.46%-444.00K
+48.76%-1.03M
Net technical trading turnover
----
----
--537.10M
--538.00M
--545.41M
--509.63M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Investment Purchase and Sale
-66.75%-60.40M
+71.69%52.59M
-96.25%596.00K
-476.66%-100.25M
-1109.48%-36.22M
+78.94%30.63M
--15.88M
---17.38M
-128.27%-3.00M
+140.45%17.12M
-100.00%0.00
+100.00%0.00
+39.22%10.60M
-239.55%-42.32M
+249.90%39.43M
+35.30%-22.49M
-78.81%7.61M
-73.74%30.33M
-78.97%11.27M
-150.70%-34.76M
Net Other Investing Changes
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
Financing Cash Flow
-92.25%-967.00K
-553.04%-5.58M
-308.49%-1.49M
-7.53%-400.00K
-1043.18%-503.00K
+50.23%-854.00K
+98.81%-365.00K
+98.82%-372.00K
+99.95%-44.00K
+96.95%-1.72M
+13.71%-30.61M
+95.65%-31.40M
-57728.57%-80.68M
-3783.98%-56.24M
-23906.71%-35.47M
-31484.69%-722.03M
-99.87%140.00K
+87.17%-1.45M
-79.95%149.00K
-137.38%-2.29M
Net Cash Flow from Continuing Financing Activities
-92.25%-967.00K
-553.04%-5.58M
-308.49%-1.49M
-7.53%-400.00K
-1043.18%-503.00K
+50.23%-854.00K
+98.81%-365.00K
+98.82%-372.00K
+99.95%-44.00K
+96.95%-1.72M
+13.71%-30.61M
+95.53%-31.40M
-57728.57%-80.68M
-3783.98%-56.24M
-23906.71%-35.47M
-30601.53%-701.84M
-99.87%140.00K
+87.17%-1.45M
-99.15%149.00K
-137.38%-2.29M
Net Issuance Payments Of Debt
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
-100.00%0.00
--0.00
Net Common Stock Issuance
-318.29%-2.10M
-581.26%-5.82M
-297.39%-1.98M
-82.26%-678.00K
-20.05%-503.00K
+50.23%-854.00K
+98.38%-498.00K
+98.82%-372.00K
+99.48%-419.00K
+96.95%-1.72M
+13.98%-30.78M
+66.84%-31.40M
-23279.25%-81.13M
-3783.98%-56.24M
-7765.05%-35.79M
-4042.56%-94.70M
-100.32%-347.00K
+74.11%-1.45M
+44.10%-455.00K
-131.61%-2.29M
Cash Dividends Paid
----
----
---1.05B
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Proceeds from Stock Option Exercised
--1.14M
--241.00K
+266.92%488.00K
--278.00K
--0.00
--0.00
-23.12%133.00K
+100.00%0.00
----
----
-44.90%173.00K
-200.00%-1.00K
----
----
-48.01%314.00K
--1.00K
----
----
-61.21%604.00K
-100.00%0.00
Proceeds from Issuance of Warrants
----
----
--1.69B
--632.38M
--627.22M
--604.61M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Other Financing Charges
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
Cash Flow from Discontinued Financing Activities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
---20.19M
----
----
--0.00
----
Ending Cash Balance
-21.98%220.60M
+159.25%288.94M
+336.52%168.64M
+625.24%175.61M
+499.32%282.76M
+103.86%111.45M
-4.33%38.63M
-66.61%24.21M
-55.67%47.18M
-71.00%54.67M
-86.50%40.38M
-82.71%72.52M
+20.77%106.43M
+98.00%188.50M
+229.32%299.01M
+243.03%419.37M
-57.17%88.13M
-17.10%95.20M
+10.32%90.80M
+29.90%122.26M
Net Change in Cash
-139.89%-68.34M
+65.20%120.30M
-148.32%-6.97M
-366.56%-107.15M
+2387.22%171.31M
+409.57%72.82M
+144.86%14.42M
+32.27%-22.97M
+90.87%-7.49M
+112.93%14.29M
+73.30%-32.14M
-110.24%-33.91M
-1059.99%-82.07M
-2607.53%-110.51M
-282.59%-120.37M
+496.58%331.25M
-107.78%-7.08M
-86.46%4.41M
-166.28%-31.46M
-629.28%-83.53M
Beginning Cash Balance
+159.25%288.94M
+336.52%168.64M
+625.24%175.61M
+499.32%282.76M
+103.86%111.45M
-4.33%38.63M
-66.61%24.21M
-55.67%47.18M
-71.00%54.67M
-86.50%40.38M
-82.71%72.52M
+20.77%106.43M
+98.00%188.50M
+229.32%299.01M
+243.03%419.37M
-57.17%88.13M
-17.10%95.20M
+10.32%90.80M
+29.90%122.26M
+94.93%205.78M
Effect of Exchange Rate Changes
----
----
--12.06M
--12.70M
--11.92M
--12.19M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Free Cash Flow
-103.35%-6.97M
+70.26%73.28M
-456.04%-6.07M
-24.89%-6.51M
+4774.01%208.04M
+3966.94%43.04M
+28.67%-1.09M
-107.86%-5.21M
+66.50%-4.45M
+90.85%-1.11M
+98.77%-1.53M
+88.65%-2.51M
+10.48%-13.29M
+53.80%-12.16M
-189.94%-124.32M
+52.50%-22.08M
+70.47%-14.84M
+63.26%-26.32M
+35.20%-42.88M
+41.22%-46.49M
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q3
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More